Kavita Natrajan
Visit Investigator ProfileInvestigation Details
Bethany Baer , Y Nguyen , Kula Jha , Thomas Ryan Withers , Oluchi Elekwachi , Peter Lenahan , Andrew Harmon , Laura Fontan , Feorillo Galivo , Natasha Thorne , Simleen Kaur , Mikhail Ovanesov , Yuqun Abigail Luo , Varsha Garnepudi , Andrey Sarafanov , Emmanuel Adu-Gyamfi , Ben Cyge , Leyish Minie , Arifa Khan , Marie Anderson , Bradley Dworak , Xiaofei Wang
Detailed Analysis
Kavita Natrajan puts a strong emphasis on the responsibility of organizations to protect patient safety. She carefully scrutinizes the data to assess the balancing act between efficacy and safety while paying close attention to any potential risks that may not have been addressed previously.
FDA Auditor Kavita Natrajan appears to be an investigator who prioritizes auditing the efficacy and safety of pharmaceutical products. Her observations often highlight any adverse effects or risks related to the medical products used. She demonstrates a thorough understanding of clinical data and has a keen eye for detail when it comes to analyzing a product’s possible side effects or health risks.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies